CLINICAL_TRIALS
trial_result
· 2017-10-06
Clinical Trial Update: Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV) [Phase 2]
Summary
Phase 2 trial update evaluating palonosetron for radiation-induced nausea and vomiting has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Edward Chow | Conditions: Nausea, Vomiting | Phase 2 | Status: COMPLETED